Registration Statement

Mineralys Therapeutics, Inc. Filed 2025-11-10 Acc 0001933414-25-000144

Documents 1

2025-11-13 4 CFO and Secretary sold 119,524 shares at an average $44.88 ($5,363,716)
2025-11-13 4 Chief Executive Officer sold 200,000 shares at an average $45.44 ($9,088,499)
2025-11-12 144 Sale of Securities
2025-11-12 144 Sale of Securities
2025-11-10 S-3ASR Registration Statement
2025-11-10 10-Q Quarterly Report
2025-11-10 8-K Results of operations

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

Loading mineralys-sx3asrnovember20.htm…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…